Micronuclei evaluation of reduction in neoadjuvant chemotherapy related acute toxicity in locally advanced lung cancer: An Indian experience

Journal of Association of Physicians of India

Volumn 54, Issue MAR., 2006, Pages 191-195

  Bahl, A ^a   Chander, S ^a   Julka, P K ^a   Rath, G K ^a   Sharma, D N ^a   Kumar, A ^a   Nair, O ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHYMOTRYPSIN; PAPAIN; TRYPSIN; WOBE MUGOS; WOBE-MUGOS;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CANCER STAGING; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; FEMALE; HUMAN; INDIA; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MICRONUCLEUS; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; CHYMOTRYPSIN; DRUG COMBINATIONS; FEMALE; HUMANS; INDIA; LUNG NEOPLASMS; MALE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PAPAIN; TRYPSIN;

EID: 33645146024     PISSN: 00045772     EISSN: 00045772     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. National Cancer Registry Programme: Consolidated Report of the Population Based Cancer Registries 1990-1996 ICMR, New Delhi (2001).
2. Shepherd FA. Induction chemotherapy for locally advanced non small cell lung cancer. Ann Thoracic Surg 1993;55: 1585-92.
3. Crino L, Latini P, Meacci M, et al. Induction chemotherapy plus high dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small cell lung cancer. Ann Oncology 1993;4:847-51.
4. Jaklitsch MT, Strauss GM, Sugarbarker DJ et al. Neoadjuvant and adjuvant therapy in management of locally advanced non small cell lung cancer. World Journal of Surgery 1993;17:729-34.
5. Darwish S, Minotti V, Crino L et al. A phase II trial of combined chemotherapy and surgery in stage III A non small cell lung cancer. Lung Cancer 1995;12(suppl. 1):S71-S78.
6. Reboul F, Brewer Y, Vincent P et al. Radiotherapy for unresectable stage III non small cell lung cancer: A phase II study. Int J Radiation Oncology Biol Phys 1996;35:343-50.
7. Wrba and Kodras. On supporting the chemotherapy of broncho-pulmonary carcinoma by proteolytic enzymes (Translated from German). Wiener Medizinische Wochenschrift 1978;5:153-8.
8. Popelia T, Kulig J, Hanisch J, Bock PR. Influence of complimentary treatment with oral enzymes on patients with colorectal cancers - an epidemiological retrolective cohort study. Cancer Chemother Pharmacol 2001;47:S55-63.
9. Countryman and Heddle. The production of micronuclei from chromosome aberration in irridiated cultures of human lymphocytes: Radiation Research 1976;41:321-32.
10. Fenech M, Morley A. Measurement of micronuclei in lymphocytes. Mutation Research 1985:29-36.
11. Benner SE, Lippman SM, WargovichMJ et al. Micronuclei a biomarker for chemoprevention trial: Results of a randomized study in oral pre malignancy. Int J Cancer 1994;59:457-9.
12. Kaul R, Mishra BK, Sutradhar P, Choudhary V, GujralMS. Acute sequale of radiation in head and neck cancers. A clinical phase III randomized trial. Indian J Cancer (June,Sept,Dec) 1999:141-8.
13. Trotti A, Byhardt R, Stez J et al. Common toxicity criteria: Version 2.0. An improved reference for grading the acute effects of cancer treatment: Impact on Radiotherapy. IJROBP 2000;47:13-47.
14. Therasse P, Arbuck SG, Elizabeth A et al. New guidelines to evaluate response to treatment in solid tumors. J Natl Cancer Inst 2000;92:3:205-16.
15. Pujol JL, Rossi JF, Chevalier TL et al. Pilot study of neoadjuvant ifosfamide, cisplatin and etoposide in locally advanced non small cell lung cancer. Eur J Cancer 1990;26:798-801.
16. Darwish S, Minotti V, Crino L et al. A phase II trial of combined chemotherapy and surgery in stage III A non small cell lung cancer. Lung Cancer 1995; 12 (suppl 1): S71-S78.
17. Hazuka MB, Crowley JJ, Bunn PA, O'Rourke M, Braun TJ, Livingstone RB. Daily low dose cisplatin plus concurrent high dose thoracic irridiation in locally advanced unresectable non small cell lung cancer: results of Southwest Oncology Group Study: Journal of Clinical Oncology 1994;12:1814-20.
18. Albain KS, Rusch VW, Crowley J, et al. Concurrent cisplatin / etoposide plus chest radiotherapy followed by surgery for stage III A (N2) and III B non small cell lung cancer. Mature results of SWOG phase II Study. JCO 1995;8:1880-92.
19. Scinto AF, Ferraresi V, Milella M et al. Ifosfamide, cisplatin and etoposide combination in locally advanced inoperable non-small cell lung cancer: a phase II study. British Journal of Cancer 1999;81:1031-6.
20. Dale PS, Tamhankar CP, George D, Daftary GV. Co - medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of reduction of acute side effects. Cancer Chemoth Pharmacol 2001;47(suppl):S29-S34.
21. Stitch HF, Rosin MP. Micronuclei in exfoliated human cells as a tool for studies in cancer risk and cancer intervention. Cancer Letters 1984;(22):241-53.
22. Perera FP, Tang D, Ricardo A et al. Molecular epidemiology of lung cancer and the modulation of markers of chronic carcinogen exposure by chemopreventive agents. Journal of Cellular Biochem 1993;17F:119-28.
23. Schneider M, Diamer K, Engelhart K, Zankl H, Trommer WE, Biesalski HK. Protective effects of vitamin C and E on the number of micronuclei in lymphocytes in smokers and their role in abscorbate free radical formation in plasma. Free Rad Research 2001;34:209-19.